- Home»
- The Billing Beat Newsletter»
- Blues highlight medical, benefit policy changes for genetic tests for Feb. 2014
Blues highlight medical, benefit policy changes for genetic tests for Feb. 2014
February 6, 2014The latest information about procedure codes and Blue Cross Blue Shield of Michigan billing guidelines are as follows. New procedures that are not covered will appear under Experimental Procedures.
| EXPERIMENTAL PROCEDURES | |
| 81500, 81503 | Basic Benefit and Medical Policy Proteomics-based testing for the evaluation of ovarian (adnexal) masses (e.g., OVA1® and ROMA™ tests) is considered experimental. The use of this testing has not been scientifically demonstrated to improve patient clinical outcomes. This policy is effective Sept. 1, 2013 |